AMRX

Amneal Pharmaceuticals, Inc.

Pharmaceuticals · Pharmaceuticals

$181.73 sample

-1.17 (-0.64%) 1D

Market cap

$720.7B

Price as of

2026-10-15

Latest filing

8-K

Alerts

8

Price$181.73 -9.47% 3M daily closessample

205.69180.18

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 07INSInsider sell: Director
Sep 29INSInsider buy: EVP, Operations
Sep 24INSInsider sell: Chief Executive Officer
Sep 18INSInsider sell: General Counsel
Sep 11INSInsider buy: General Counsel
Sep 03INSInsider sell: Director
Aug 25INSInsider buy: Director
Aug 20INSInsider buy: General Counsel

Sign up to see the real AMRX record →

Company facts

SEC EDGAR registration

Name: Amneal Pharmaceuticals, Inc.
Sector: Pharmaceuticals
Industry: Pharmaceuticals
Smart-money score: +26sample, -100 to +100
Reporting currency: USD

Who is positioning in AMRX

sample

Insiders: 21 insider transactions over 90 days, net selling, $291.8M
Congress: 3 members traded over 90 days
Institutions · 13F: 29 funds hold $16.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$45.8B +16.1% y/y

Q4 2024Q3 2026

Inventory$26.7B +14.1% y/y

Q4 2024Q3 2026

Accounts receivable$19.3B +7.7% y/y

Q4 2024Q3 2026

Total debt$52.3B +9.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $425.0B +12.4% 3M
Sample peer B: $251.8B +16.4% 3M
Sample peer C: $114.5B +3.4% 3M
Sample peer D: $435.7B -8.6% 3M
Sample peer E: $309.0B +1.7% 3M